123I-IMT SPET: introducing another research tool into clinical neuro-oncology?

[1]  O. Schober,et al.  Kinetic parameters of 3-[123I]iodo-L-α-methyl tyrosine ([123I]IMT) transport in human GOS3 glioma cells , 2001 .

[2]  K. Langen,et al.  Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  M Schwaiger,et al.  First experience with I-123-alpha-methyl-tyrosine spect in the 3-D radiation treatment planning of brain gliomas. , 2000, International journal of radiation oncology, biology, physics.

[4]  O. Schober,et al.  Sequential scintigraphic strategy for the differentiation of brain tumours , 2000, European Journal of Nuclear Medicine.

[5]  M. Weckesser,et al.  Evaluation of the Extension of Cerebral Gliomas by Scintigraphy , 2000, Strahlentherapie und Onkologie.

[6]  O. Schober,et al.  Kinetics of 3-[123I]iodo-l-α-methyltyrosine transport in rat C6 glioma cells , 1999, European Journal of Nuclear Medicine.

[7]  J. Moringlane,et al.  Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy , 1999, European Journal of Nuclear Medicine.

[8]  F. Barral,et al.  Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy , 1998, European Journal of Nuclear Medicine.

[9]  M. Sasaki,et al.  A comparative study of thallium-201 SPET, carbon-11 methionine PET and fluorine-18 fluorodeoxyglucose PET for the differentiation of astrocytic tumours , 1998, European Journal of Nuclear Medicine.

[10]  A. Soricelli,et al.  Technetium-99m-tetrofosmin uptake in brain tumors by SPECT: comparison with thallium-201 imaging. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  O. Schober,et al.  Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  S. Goldman,et al.  Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  H. Herzog,et al.  3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  F. Fazio,et al.  Clinical brain radionuclide imaging studies. , 1995, Seminars in nuclear medicine.

[15]  K. Sartor,et al.  Early Postoperative Magnetic Resonance Imaging after Resection of Malignant Glioma: Objective Evaluation of Residual Tumor and Its Influence on Regrowth and Prognosis , 1995 .

[16]  K Herholz,et al.  Correlation of glucose consumption and tumor cell density in astrocytomas. A stereotactic PET study. , 1993, Journal of neurosurgery.

[17]  H. Herzog,et al.  Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  J M Hoffman,et al.  Clinical application of PET for the evaluation of brain tumors. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[19]  H. Herzog,et al.  SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  M. Bergström,et al.  Positron Emission Tomography with 11C-Methionine and Computed Tomography of Intracranial Tumours Compared with Histopathologic Examination of Multiple Biopsies , 1987, Acta radiologica.

[21]  O. Schober,et al.  Kinetic parameters of 3-[(123)I]iodo-L-alpha-methyl tyrosine ([(123)I]IMT) transport in human GOS3 glioma cells. , 2001, Nuclear Medicine and Biology.

[22]  O. Schober,et al.  Kinetics of 3 , 1999 .

[23]  O. Schober,et al.  Kinetics of 3-[(123)I]iodo-l-alpha-methyltyrosine transport in rat C6 glioma cells. , 1999, European journal of nuclear medicine.

[24]  O. Schober,et al.  Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[25]  O. Schober,et al.  Diagnosis of recurrent glioma with SPECT and iodine-123-α-methyl tyrosine , 1998 .

[26]  Susan M. Chang,et al.  18‐fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma , 1997, Cancer.

[27]  O. Schober,et al.  Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. , 1996, European journal of nuclear medicine.

[28]  O. Schober,et al.  Brain tumor imaging using C-11-labeled L-methionine and D-methionine. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  F. Barral,et al.  Technetium-99 m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy , 2022 .